trial · primary record
ELI-002 7P
Pancreatic Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2028-06 |
| Primary endpoint | the proportion of patients with a Grade 3 or higher drug-related adverse event (AE) |
| Registry ID | NCT07671339 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:42:49.995Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07671339
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.